1. Home
  2. VRDN vs CLBK Comparison

VRDN vs CLBK Comparison

Compare VRDN & CLBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • CLBK
  • Stock Information
  • Founded
  • VRDN 2006
  • CLBK 1927
  • Country
  • VRDN United States
  • CLBK United States
  • Employees
  • VRDN N/A
  • CLBK N/A
  • Industry
  • VRDN Medical Specialities
  • CLBK Savings Institutions
  • Sector
  • VRDN Health Care
  • CLBK Finance
  • Exchange
  • VRDN Nasdaq
  • CLBK Nasdaq
  • Market Cap
  • VRDN 1.3B
  • CLBK 1.6B
  • IPO Year
  • VRDN N/A
  • CLBK N/A
  • Fundamental
  • Price
  • VRDN $18.54
  • CLBK $14.54
  • Analyst Decision
  • VRDN Strong Buy
  • CLBK Hold
  • Analyst Count
  • VRDN 11
  • CLBK 1
  • Target Price
  • VRDN $38.80
  • CLBK $16.00
  • AVG Volume (30 Days)
  • VRDN 767.6K
  • CLBK 111.4K
  • Earning Date
  • VRDN 08-06-2025
  • CLBK 07-30-2025
  • Dividend Yield
  • VRDN N/A
  • CLBK N/A
  • EPS Growth
  • VRDN N/A
  • CLBK N/A
  • EPS
  • VRDN N/A
  • CLBK 0.06
  • Revenue
  • VRDN $305,000.00
  • CLBK $187,256,000.00
  • Revenue This Year
  • VRDN N/A
  • CLBK $31.86
  • Revenue Next Year
  • VRDN $17,102.33
  • CLBK $13.37
  • P/E Ratio
  • VRDN N/A
  • CLBK $239.96
  • Revenue Growth
  • VRDN 5.90
  • CLBK N/A
  • 52 Week Low
  • VRDN $9.90
  • CLBK $12.64
  • 52 Week High
  • VRDN $27.20
  • CLBK $19.28
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 62.06
  • CLBK 50.49
  • Support Level
  • VRDN $15.68
  • CLBK $13.98
  • Resistance Level
  • VRDN $19.10
  • CLBK $15.14
  • Average True Range (ATR)
  • VRDN 1.01
  • CLBK 0.37
  • MACD
  • VRDN 0.08
  • CLBK 0.06
  • Stochastic Oscillator
  • VRDN 83.63
  • CLBK 52.40

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About CLBK Columbia Financial Inc.

Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a community-minded, customer service-focused institution. It offers traditional financial services to businesses and consumers. It attracts deposits from the general public and uses those funds to originate a variety of loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans, and also offers a broad range of insurance products, investment solutions, and wealth management services.

Share on Social Networks: